Literature DB >> 27390907

Total Synthesis of the Hamigerans.

Xiaojun Li1, Dongsheng Xue1, Cheng Wang1, Shuanhu Gao2.   

Abstract

The first total synthesis of hamigerans D, G, L, and N-Q has been accomplished. A convergent approach was used to build the basic tricarbocyclic ring system bearing a 5-6-6 structure. A sequence of oxidative cleavage, homologation, and ring regeneration provided access to the 5-7-6 skeleton of hamigeran G. Based on the biogenetic hypothesis, elegant and highly efficient biomimetic transformations of hamigeran G into hamigerans D, N-Q, and L were achieved.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  biomimetic synthesis; cross-couplings; heterocycles; natural products; total synthesis

Mesh:

Substances:

Year:  2016        PMID: 27390907     DOI: 10.1002/anie.201604070

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  5 in total

1.  Synthetic Studies toward the Hamigerans with a 6-7-5 Tricyclic Core.

Authors:  Baiyang Jiang; Mingji Dai
Journal:  Org Lett       Date:  2020-05-13       Impact factor: 6.005

2.  11-Step and Scalable Total Synthesis of Hamigeran M Enabled by Five C-H Functionalizations.

Authors:  Baiyang Jiang; Mingji Dai
Journal:  J Am Chem Soc       Date:  2021-11-23       Impact factor: 16.383

3.  Total synthesis of cyrneines A-B and glaucopine C.

Authors:  Guo-Jie Wu; Yuan-He Zhang; Dong-Xing Tan; Fu-She Han
Journal:  Nat Commun       Date:  2018-06-01       Impact factor: 14.919

4.  Progress towards the total synthesis of hamigerans C and D: a direct approach to an elaborated 6-7-5 carbocyclic core.

Authors:  Douglas Charles Duquette; Thomas Jensen; Brian Mark Stoltz
Journal:  J Antibiot (Tokyo)       Date:  2017-09-06       Impact factor: 2.649

5.  Synthesis and Biological Evaluation of Diversified Hamigeran B Analogs as Neuroinflammatory Inhibitors and Neurite Outgrowth Stimulators.

Authors:  Ruo-Xin Li; Rui Han; Guo-Jie Wu; Fu-She Han; Jin-Ming Gao
Journal:  Mar Drugs       Date:  2020-06-11       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.